1798 related articles for article (PubMed ID: 10370639)
21. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation.
Mazzucchelli L; Hauser C; Zgraggen K; Wagner H; Hess M; Laissue JA; Mueller C
Am J Pathol; 1994 May; 144(5):997-1007. PubMed ID: 8178948
[TBL] [Abstract][Full Text] [Related]
22. Ulcerative colitis and Crohn's disease of the colon. Is there a macroscopic difference?
Palnaes Hansen C; Hegnhøj J; Møller A; Brauer C; Hage E; Jarnum S
Ann Chir Gynaecol; 1990; 79(2):78-81. PubMed ID: 2386361
[TBL] [Abstract][Full Text] [Related]
23. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
24. Regional distribution and alterations of lectin binding to colorectal mucin in mucosal biopsies from controls and subjects with inflammatory bowel diseases.
Jacobs LR; Huber PW
J Clin Invest; 1985 Jan; 75(1):112-8. PubMed ID: 3965499
[TBL] [Abstract][Full Text] [Related]
25. Circulating and mucosal concentrations of tumour necrosis factor and inhibitor(s) in chronic inflammatory bowel disease.
Nielsen OH; Brynskov J; Bendtzen K
Dan Med Bull; 1993 Apr; 40(2):247-9. PubMed ID: 8495600
[TBL] [Abstract][Full Text] [Related]
26. [Immunohistological study of T-lymphocytes (total and helper) and B-lymphocytes of the colonic mucosa in children with Crohn's disease and non-specific ulcerative colitis].
Rodrigues M; Zerbini MC; Barbieri D
Arq Gastroenterol; 1998; 35(3):223-36. PubMed ID: 10029869
[TBL] [Abstract][Full Text] [Related]
27. Intestinal mucosa diamine oxidase activity reflects intestinal involvement in Crohn's disease.
Thompson JS; Burnett DA; Markin RS; Vaughan WP
Am J Gastroenterol; 1988 Jul; 83(7):756-60. PubMed ID: 3132852
[TBL] [Abstract][Full Text] [Related]
28. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
[TBL] [Abstract][Full Text] [Related]
29. [Levels of cytokines in mucosal biopsies of Crohn's colitis. Physiopatological observations].
Marongiu L; Scintu F; Melis MV; Pisano M; Zorcolo L; Capra F; Casula G
Minerva Chir; 2002 Feb; 57(1):35-40. PubMed ID: 11832856
[TBL] [Abstract][Full Text] [Related]
30. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease.
Bernstein CN; Robert ME; Eysselein VE
Am J Gastroenterol; 1993 Jun; 88(6):908-13. PubMed ID: 7684884
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory bowel disease-related lesions in the duodenal and gastric mucosa.
Danelius M; Ost A; Lapidus AB
Scand J Gastroenterol; 2009; 44(4):441-5. PubMed ID: 19110988
[TBL] [Abstract][Full Text] [Related]
32. Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease.
Strugala V; Dettmar PW; Pearson JP
Int J Clin Pract; 2008 May; 62(5):762-9. PubMed ID: 18194279
[TBL] [Abstract][Full Text] [Related]
33. Immunoglobulin production by isolated intestinal mononuclear cells from patients with ulcerative colitis and Crohn's disease.
Wu KC; Mahida YR; Priddle JD; Jewell DP
Clin Exp Immunol; 1989 Oct; 78(1):37-41. PubMed ID: 2805422
[TBL] [Abstract][Full Text] [Related]
34. Real-time PCR quantification analysis of five mucosal transcripts in patients with Crohn's disease.
Eriksson A; Jennische E; Flach CF; Jorge A; Lange S
Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):290-6. PubMed ID: 18334872
[TBL] [Abstract][Full Text] [Related]
35. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
Pimentel M; Chang M; Chow EJ; Tabibzadeh S; Kirit-Kiriak V; Targan SR; Lin HC
Am J Gastroenterol; 2000 Dec; 95(12):3458-62. PubMed ID: 11151877
[TBL] [Abstract][Full Text] [Related]
36. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
37. Microaggregate of immunostained macrophages in noninflamed gastroduodenal mucosa: a new useful histological marker for differentiating Crohn's colitis from ulcerative colitis.
Yao K; Yao T; Iwashita A; Matsui T; Kamachi S
Am J Gastroenterol; 2000 Aug; 95(8):1967-73. PubMed ID: 10950044
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
Niederau C; Backmerhoff F; Schumacher B; Niederau C
Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
[TBL] [Abstract][Full Text] [Related]
39. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation.
Casini-Raggi V; Kam L; Chong YJ; Fiocchi C; Pizarro TT; Cominelli F
J Immunol; 1995 Mar; 154(5):2434-40. PubMed ID: 7868909
[TBL] [Abstract][Full Text] [Related]
40. Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease.
Palatka K; Serfozo Z; Veréb Z; Hargitay Z; Lontay B; Erdodi F; Bánfalvi G; Nemes Z; Udvardy M; Altorjay I
Scand J Gastroenterol; 2005 Jun; 40(6):670-80. PubMed ID: 16036527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]